BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31541281)

  • 1. The same mutation in a family with adenosine deaminase 2 deficiency.
    Sozeri B; Ercan G; Dogan OA; Yıldız J; Demir F; Doğanay L
    Rheumatol Int; 2021 Jan; 41(1):227-233. PubMed ID: 31541281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency.
    Sahin S; Adrovic A; Barut K; Ugurlu S; Turanli ET; Ozdogan H; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):129-136. PubMed ID: 28516235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2.
    Çakan M; Aktay-Ayaz N; Karadağ ŞG; Tahir-Turanlı E; Stafstrom K; Bainter W; Geha RS; Chou J
    Turk J Pediatr; 2019; 61(3):413-417. PubMed ID: 31916720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation.
    Skrabl-Baumgartner A; Plecko B; Schmidt WM; König N; Hershfield M; Gruber-Sedlmayr U; Lee-Kirsch MA
    Pediatr Rheumatol Online J; 2017 Aug; 15(1):67. PubMed ID: 28830446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
    Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
    Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
    Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
    Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature].
    Fayand A; Sarrabay G; Belot A; Hentgen V; Kone-Paut I; Grateau G; Melki I; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):297-306. PubMed ID: 29273180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
    Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
    [No Abstract]   [Full Text] [Related]  

  • 10. Importance of the determination of enzymatic activity in the diagnosis of deficiency of adenosine deaminase 2 (DADA2).
    Abbasi A; Batllori M; Gil-Sáez FJ; Rodríguez-Pintó I; Antón López J; Iglesias Jímenez E
    Med Clin (Barc); 2022 Sep; 159(6):283-286. PubMed ID: 35241284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
    Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
    Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
    Pinto B; Deo P; Sharma S; Syal A; Sharma A
    Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous vasculitis in autoinflammatory diseases.
    Chen KR
    J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching NeuroImages: Lacunar stroke and polyarteritis nodosa: Consider ADA2 deficiency (DADA2).
    Gonçalves TDS; Alves CAPF; da Paz JA; Lucato LT
    Neurology; 2019 Apr; 92(15):e1801-e1802. PubMed ID: 30962308
    [No Abstract]   [Full Text] [Related]  

  • 15. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
    Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S
    Front Immunol; 2022; 13():869570. PubMed ID: 35592317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
    Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of Adenosine Deaminase 2 in Adults and Children: Experience From India.
    Sharma A; Naidu G; Sharma V; Jha S; Dhooria A; Dhir V; Bhatia P; Sharma V; Bhattad S; Chengappa KG; Gupta V; Misra DP; Chavan PP; Malaviya S; Dudam R; Sharma B; Kumar S; Bhojwani R; Gupta P; Agarwal V; Sharma K; Singhal M; Rathi M; Nada R; Minz RW; Chaturvedi V; Aggarwal A; Handa R; Grossi A; Gattorno M; Huang Z; Wang J; Jois R; Negi VS; Khubchandani R; Jain S; Arostegui JI; Chambers EP; Hershfield MS; Aksentijevich I; Zhou Q; Lee PY
    Arthritis Rheumatol; 2021 Feb; 73(2):276-285. PubMed ID: 32892503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
    Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
    Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.